PILA Share Price Performance
SEK 2.22
-1.67 (-42.93%)
Price SEK 2.22
Share Pricen/a
Pila Pharma AB (publ) Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
PILA Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Pila Pharma AB (publ) Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Feb 26, 2026
- -0.27
- 18.78%
- -1,175.22%
- 0%
About PILA
- Founded
- 2014
- Employees
- 1
- CEO
- WebsiteView website
Pila Pharma AB (publ) operates as a clinical stage biotech company in Sweden. The company develops XEN-D0501, a TRPV1 antagonist in Phase 2a trial for obesity, diabetes, and heart failure; Phase 1 trial for erythromelalgia, inflammation pain, and rare diseases; and preclinical trial for abdominal aorta aneurism and cardiovascular diseases. Pila Pharma AB (publ) was incorporated in 2014 and is headquartered in Malmö, Sweden.
